Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 64, Issue 11, 2012, Pages 3715-3725

  Fan, Wei ^a   Liang, Dong ^b   Tang, Yuanjia ^a   Qu, Bo ^a   Cui, Huijuan ^a   Luo, Xiaobing ^a   Huang, Xinfang ^a   Chen, Shunle ^a   Higgs, Brandon W ^c   Jallal, Bahija ^c   Yao, Yihong ^c   Harley, John B ^b   Shen, Nan ^d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c MEDIMMUNE   (United States)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA; MICRORNA 31; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPORTER GENE; RNA ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; WESTERN BLOTTING;

GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; NFATC TRANSCRIPTION FACTORS; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84864865406     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34596     Document Type: Article

References (51)

1. Fairhurst AM, Wandstrat AE, Wakeland EK,. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006; 92: 1-69.
2. Anders HJ,. Pseudoviral immunity-a novel concept for lupus. Trends Mol Med 2009; 15: 553-61.
3. Nambiar MP, Krishnan S, Tsokos GC,. T-cell signaling abnormalities in human systemic lupus erythematosus. Methods Mol Med 2004; 102: 31-47.
4. Fujii Y, Fujii K, Tanaka Y,. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. Autoimmun Rev 2006; 5: 143-4.
5. Kong PL, Odegard JM, Bouzahzah F, Choi JY, Eardley LD, Zielinski CE, et al. Intrinsic T cell defects in systemic autoimmunity. Ann N Y Acad Sci 2003; 987: 60-7.
6. Moulton VR, Tsokos GC,. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: 207.
7. Lieberman LA, Tsokos GC,. The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol 2010; 2010: 740619.
8. Tenbrock K, Tsokos GC,. Transcriptional regulation of interleukin 2 in SLE T cells. Int Rev Immunol 2004; 23: 333-45.
9. Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC,. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 2005; 115: 3193-204.
10. Juang YT, Wang Y, Solomou EE, Li Y, Mawrin C, Tenbrock K, et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 2005; 115: 996-1005.
11. Herndon TM, Juang YT, Solomou EE, Rothwell SW, Gourley MF, Tsokos GC,. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 2002; 103: 145-53.
12. Solomou EE, Juang YT, Gourley MF, Kammer GM, Tsokos GC,. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 2001; 166: 4216-22.
13. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ,. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-5.
14. Gregory RI, Tops BB, Plasterk RH, Ketting RF, Hannon GJ,. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-40.
15. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-5.
16. Pauley KM, Cha S, Chan EK,. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009; 32: 189-94.
17. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142: 914-29.
18. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33: 607-19.
19. Pauley KM, Chan EK,. MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci 2008; 1143: 226-39.
20. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-75.
21. + T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184: 6773-81.
22. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011; 63: 1376-86.
23. Yu D, Vinuesa CG,. Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell Mol Immunol 2010; 7: 198-203.
24. Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010; 11: 1057-62.
25. Yu JY, Reynolds SH, Hatfield SD, Shcherbata HR, Fischer KA, Ward EJ, et al. Dicer-1-dependent Dacapo suppression acts downstream of Insulin receptor in regulating cell division of Drosophila germline stem cells. Development 2009; 136: 1497-507.
26. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010; 115: 265-73.
27. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-8.
28. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608-11.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
31. Ahmed Z, Dent RG, Suggate EL, Barrett LB, Seabright RJ, Berry M, et al. Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A. Mol Cell Neurosci 2005; 28: 509-23.
32. Chow CW, Rincon M, Davis RJ,. Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol 1999; 19: 2300-7.
33. Helms WS, Jeffrey JL, Holmes DA, Townsend MB, Clipstone NA, Su L,. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J Leukoc Biol 2007; 82: 361-9.
34. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009; 137: 1032-46.
35. Katsiari CG, Tsokos GC,. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmun Rev 2006; 5: 118-21.
36. Setoguchi R, Hori S, Takahashi T, Sakaguchi S,. Homeostatic maintenance of natural Foxp3+CD25+CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201: 723-35.
37. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY,. A function for interleukin 2 in Foxp3-expressing regulatory T cells [published erratum appears in Nat Immunol 2006;7:427]. Nat Immunol 2005; 6: 1142-51.
38. Crispin JC, Tsokos GC,. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 2009; 8: 190-5.
39. Gomez-Martin D, Díaz-Zamudio M, Crispin JC, Alcocer-Varela J,. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun Rev 2009; 9: 34-9.
40. Nambiar MP, Fisher CU, Kumar A, Tsokos CG, Warke VG, Tsokos GC,. Forced expression of the Fc receptor γ-chain renders human T cells hyperresponsive to TCR/CD3 stimulation. J Immunol 2003; 170: 2871-6.
41. Nambiar MP, Fisher CU, Warke VG, Krishnan S, Mitchell JP, Delaney N, et al. Reconstitution of deficient T cell receptor χ chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 2003; 48: 1948-55.
42. Bodor J, Fehervari Z, Diamond B, Sakaguchi S,. Regulatory T cell-mediated suppression: potential role of ICER. J Leukoc Biol 2007; 81: 161-7.
43. Bodor J, Bodorova J, Gress RE,. Suppression of T cell function: a potential role for transcriptional repressor ICER. J Leukoc Biol 2000; 67: 774-9.
44. Bodor J, Habener JF,. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J Biol Chem 1998; 273: 9544-51.
45. Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N,. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 2005; 4: 2032-42.
46. Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W, et al. Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 2008; 35: 804-10.
47. Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 2010; 70: 1906-15.
48. Schmidt KN, Ouyang W,. Targeting interferon-α: a promising approach for systemic lupus erythematosus therapy. Lupus 2004; 13: 348-52.
49. Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, et al. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Cytokine 2000; 12: 1035-41.
50. Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, Flotte TR, et al. IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 2006; 86: 1136-48.
51. Prud'homme GJ,. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J Gene Med 2000; 2: 222-32.